Literature DB >> 2676522

Asparaginase as a drug for treatment of acute lymphoblastic leukaemia.

M P Gallagher1, R D Marshall, R Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2676522

Source DB:  PubMed          Journal:  Essays Biochem        ISSN： 0071-1365            Impact factor:   8.000


× No keyword cloud information.
  9 in total

Review 1.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

2.  Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.

Authors:  C Derst; J Henseling; K H Röhm
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

3.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

4.  L-asparaginase kills lymphoma cells by apoptosis.

Authors:  M D Story; D W Voehringer; L C Stephens; R E Meyn
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Purification, characterization and antitumor activity of L-asparaginase isolated from Pseudomonas stutzeri MB-405.

Authors:  S Manna; A Sinha; R Sadhukhan; S L Chakrabarty
Journal:  Curr Microbiol       Date:  1995-05       Impact factor: 2.188

6.  PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation.

Authors:  Young Min Kwon; Yong Tao Li; Jun F Liang; Yoon Jeong Park; Li-Chien Chang; Victor C Yang
Journal:  J Control Release       Date:  2008-06-26       Impact factor: 9.776

7.  Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.

Authors:  Alejandro Huerta-Saquero; Zahaed Evangelista-Martínez; Angélica Moreno-Enriquez; Ernesto Perez-Rueda
Journal:  Bioengineered       Date:  2012-08-16       Impact factor: 3.269

8.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13

9.  Purification and Characterization of Asparaginase from Phaseolus vulgaris Seeds.

Authors:  Saleh A Mohamed; Mohamed F Elshal; Taha A Kumosani; Alia M Aldahlawi
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.